Company Number: 13646133

Analysis Date: 2025-07-20 14:08 UTC

Financial Health Assessment Report for MICROSYSTEMS INVESTMENTS LTD

---

1. Financial Health Score: Grade C

Explanation:
This company exhibits basic financial stability with positive net current assets and net assets, but with very limited scale and minimal working capital. The financials show a company at an early stage or one with very low operational activity. The low asset base and slim net asset buffer suggest vulnerability to unexpected expenses or downturns. The score reflects a stable but fragile financial condition, requiring vigilance and growth to improve resilience.

---

2. Key Vital Signs

Metric	2023 Value	Interpretation
Current Assets	£2,051	Very low cash and short-term assets; slight growth from prior years.
Current Liabilities	£1,858	Almost equal to current assets, tight liquidity position.
Net Current Assets (Working Capital)	£193	Positive but minimal cushion to meet short-term obligations.
Net Assets (Equity)	£193	Positive but very small equity base, indicates limited capitalization.
Number of Employees	2	Small workforce consistent with micro-entity status.
Shareholder’s Funds	£193	Reflects retained earnings or capital contributions, very modest.

Interpretation:

• The company’s working capital is positive but extremely narrow, akin to a patient with a low but stable pulse—enough to sustain immediate needs but with little buffer for stress.
• The net assets are positive, indicating no insolvency symptoms currently, but the low figure signals vulnerability to losses or liabilities.
• The company qualifies as a micro-entity, so scale and complexity are minimal, which aligns with the low asset and liability values.
• Growth in current assets from £100 in 2022 to £2,051 in 2023 is a positive sign but remains small in absolute terms.
• No debts due beyond one year or fixed assets reported, showing a simple asset structure.

---

3. Diagnosis: Financial Condition Overview

MICROSYSTEMS INVESTMENTS LTD is a micro-sized investment company with minimal financial complexity and a small operational footprint. The "symptoms" in the financials suggest a startup or holding entity with limited transactions and modest financial activity. The healthy, though very modest, positive working capital indicates the company is not currently in financial distress but remains at risk due to its thin equity base and tight liquidity.

The company’s financial health resembles a patient recovering or in stable remission but requiring monitoring and strengthening to avoid relapse. The limited scale means it is susceptible to shocks, such as unexpected expenses or loss of capital. The absence of long-term liabilities or fixed assets reduces financial risk but also suggests limited growth investments.

---

4. Recommendations: Actions to Improve Financial Wellness

• Enhance Working Capital Cushion: Consider increasing cash reserves or short-term assets to build a more robust buffer against operational costs and unexpected liabilities. This is akin to improving a patient's immunity to stress.
• Capital Injection or Retained Earnings Growth: Strengthen shareholders’ funds by reinvesting profits or injecting fresh capital to improve net asset base, enhancing solvency and creditworthiness.
• Cost Control and Revenue Growth: Focus on increasing business activity or investment returns to expand current assets, improve liquidity, and build retained earnings.
• Regular Financial Monitoring: Maintain close oversight on cash flows and liabilities to detect early warning signs of liquidity stress.
• Maintain Compliance and Timely Filings: Continue timely submission of accounts and confirmation statements to avoid penalties and maintain stakeholder confidence.
• Consider Strategic Partnerships or Investment: To scale operations or diversify assets to reduce concentration risk.

---